samedan logo
 
 
spacer
home > pmps > spring 2003 > child-resistant blister packs
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Child-Resistant Blister Packs

In recent years claims that non-reclosable flexible packaging for pharmaceutical solid dose products - in particular blisters - are not child safe have become more frequent. The Child Safety Packaging Group in the UK has been lobbying for a relative standard since 1995 and increased their activities following the lethal ingestion of 44 tablets containing ferrous-sulphate by a three year old boy - tablets that had allegedly been packed in blisters, although no evidence to prove this was produced.

Following a public debate it was decided that the UK would introduce a British standard and not wait for the Centre Européen de Normalisation (CEN) to present a European standard so that the MCA could revise its legislation.

The idea of child-resistant packaging was first introduced in the US by the Code of Federal Regulation in 1974. While the importance and benefits of legislation are widely accepted and regulation regarding potentially harmful household product is covered by EU Directives, only four member states have legislation covering pharmaceuticals. Germany introduced DIN 55559 in 1980 with the Netherlands following closely behind. In Italy testing does not allow the involvement of children but accepts child-resistant packaging as soon as it has been recognised as being child-resistant in another EU member state.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Tassilo Korab, Director, Head of the Business Unit Pharma Packaging at Teich


After studying Economics in Vienna, Tassilo Korab started his career as an International Sales Manager and has been in the packaging industry for more than 15 years. Now based at Teich in Austria, he is responsible for pharmaceutical packaging materials produced by Constantia Verpackungen AG, of which Teich is part.


spacer
Tassilo Korab
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

First own Gerresheimer Autoinjector - Gerresheimer and Midas Pharma announce strategic partnership

– Gerresheimer’s first own IP autoinjector suitable for both small and large molecules enhances broad portfolio of solutions, medical devices and pharmaceutical primary packaging – First joint project of Gerresheimer and Midas Pharma: Development and marketing of new autoinjector – One-stop-shop for biotech and pharma customers Duesseldorf, November 08, 2021 – Gerresheimer acquired the IP of a new generation cartridge based autoinjector from Midas Pharma. This is the start of a strategic partnership. The joint project comprises the development and marketing of the new generation autoinjector.
More info >>

White Papers

Modifying MDI Canister Surfaces to Improve Drug Stability & Drug Delivery

Presspart Manufacturing Ltd

Hydrofluoroalkane (HFA)-based propellants are widely used in modern metered-dose inhalers (MDIs), due to their lack hazardous and environmentally-damaging effects. However, an HFA's active pharmaceutical ingredient can interact with the canister substrate, causing deposition of the drug to the canister walls, or interact with the solution, causing degradation and resulting in increased impurity levels. Over the past few years, a number of surface coatings have been developed that can be applied to MDI canisters and valve components, to protect the contents from deposition and degradation. More recently, plasma processes have been developed to modify and improve the surface energy performance of a MDI canister. This approach has a number of advantages to alternative coatings but requires careful optimisation to ensure the highest quality finish and MDI performance. Richard Turner, Business Development Director, Presspart Manufacturing Ltd, explains.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement